# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-033387
Filing Date
2026-03-23
Accepted
2026-03-23 16:59:27
Documents
49
Period of Report
2026-05-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | abbv-20260508xdef14a.htm iXBRL | DEF 14A | 3133527
2 | GRAPHIC | abbv-20260508xdef14a_a001.jpg | GRAPHIC | 9585
3 | GRAPHIC | abbv-20260508xdef14a_a002.jpg | GRAPHIC | 2903
4 | GRAPHIC | abbv-20260508xdef14a_a003.jpg | GRAPHIC | 3106
5 | GRAPHIC | abbv-20260508xdef14a_a004.jpg | GRAPHIC | 2040
6 | GRAPHIC | abbv-20260508xdef14a_a005.jpg | GRAPHIC | 3499
7 | GRAPHIC | abbv-20260508xdef14a_a006.jpg | GRAPHIC | 3703
8 | GRAPHIC | abbv-20260508xdef14a_a007.jpg | GRAPHIC | 4669
9 | GRAPHIC | abbv-20260508xdef14a_a008.jpg | GRAPHIC | 2923
10 | GRAPHIC | abbv-20260508xdef14a_a009.jpg | GRAPHIC | 8364
11 | GRAPHIC | abbv-20260508xdef14a_a012.jpg | GRAPHIC | 3300
12 | GRAPHIC | abbv-20260508xdef14a_a013.jpg | GRAPHIC | 1714
13 | GRAPHIC | abbv-20260508xdef14a_a014.jpg | GRAPHIC | 1778
14 | GRAPHIC | abbv-20260508xdef14a_a019.jpg | GRAPHIC | 4128
15 | GRAPHIC | abbv-20260508xdef14a_a020.jpg | GRAPHIC | 5494
16 | GRAPHIC | abbv-20260508xdef14a_a021.jpg | GRAPHIC | 5753
17 | GRAPHIC | abbv-20260508xdef14a_a022.jpg | GRAPHIC | 11549
18 | GRAPHIC | abbv-20260508xdef14a_a025.jpg | GRAPHIC | 6532
19 | GRAPHIC | abbv-20260508xdef14a_a026.jpg | GRAPHIC | 7966
20 | GRAPHIC | abbv-20260508xdef14a_a027.jpg | GRAPHIC | 6975
21 | GRAPHIC | abbv-20260508xdef14a_a028.jpg | GRAPHIC | 5185
22 | GRAPHIC | abbv-20260508xdef14a_a029.jpg | GRAPHIC | 6058
23 | GRAPHIC | abbv-20260508xdef14a_a030.jpg | GRAPHIC | 6261
24 | GRAPHIC | abbv-20260508xdef14a_a031.jpg | GRAPHIC | 7584
25 | GRAPHIC | abbv-20260508xdef14a_a032.jpg | GRAPHIC | 6704
26 | GRAPHIC | abbv-20260508xdef14a_a033.jpg | GRAPHIC | 6514
27 | GRAPHIC | abbv-20260508xdef14a_a034.jpg | GRAPHIC | 6992
28 | GRAPHIC | abbv-20260508xdef14a_a035.jpg | GRAPHIC | 6848
29 | GRAPHIC | abbv-20260508xdef14a_a036.jpg | GRAPHIC | 5887
30 | GRAPHIC | abbv-20260508xdef14a_a050.jpg | GRAPHIC | 57015
31 | GRAPHIC | abbv-20260508xdef14a_a051.jpg | GRAPHIC | 60113
32 | GRAPHIC | abbv-20260508xdef14a_a064.jpg | GRAPHIC | 54496
33 | GRAPHIC | abbv-20260508xdef14a_a065.jpg | GRAPHIC | 50713
34 | GRAPHIC | abbv-20260508xdef14a_bg001.jpg | GRAPHIC | 116801
35 | GRAPHIC | abbv-20260508xdef14a_bg002.jpg | GRAPHIC | 127871
| Complete submission text file | 0001104659-26-033387.txt |  | 6729834

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
36 | EX-101.SCH | abbv-20260508.xsd | EX-101.SCH | 5755
37 | EX-101.DEF | abbv-20260508_def.xml | EX-101.DEF | 6776
38 | EX-101.LAB | abbv-20260508_lab.xml | EX-101.LAB | 13303
39 | EX-101.PRE | abbv-20260508_pre.xml | EX-101.PRE | 9057
52 | EXTRACTED XBRL INSTANCE DOCUMENT | abbv-20260508xdef14a_htm.xml | XML | 751161

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35565 | Film No.: 26783100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)